Review
Gastroenterology & Hepatology
Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana
Summary: Significant progress has been made in the treatment of metastatic colorectal cancer (mCRC) over the past 20 years. Various treatment options are available for first-line treatment of mCRC. Advanced molecular technologies have identified new prognostic and predictive biomarkers for CRC. The development of next-generation sequencing and whole-exome sequencing has greatly advanced DNA sequencing technology and facilitated customized treatment delivery.
WORLD JOURNAL OF GASTROENTEROLOGY
(2023)
Review
Pharmacology & Pharmacy
Klara Dorman, Volker Heinemann, Sebastian Kobold, Michael Von Bergwelt-Baildon, Stefan Boeck
Summary: With a 5-year overall survival rate of 10%, more effective therapies are needed for metastatic PDAC. Emerging drugs in clinical development, including cellular therapies, are being investigated to overcome the challenges of the immunosuppressive tumor microenvironment, poor vascularization, and dense tumor stroma typical for PDAC. Exciting clinical trials are ongoing, with a focus on targeted treatments and personalized therapy plans for PDAC patients.
EXPERT OPINION ON INVESTIGATIONAL DRUGS
(2022)
Article
Biochemistry & Molecular Biology
Mariam Al-Bahrani, Paladd Asavarut, Sajee Waramit, Keittisak Suwan, Amin Hajitou
Summary: Medulloblastoma is a common childhood brain tumor with limited treatment options and poor prognosis. Researchers have developed a tumor-targeted bacteriophage-derived particle called TPA to deliver a gene expressing the tumor necrosis factor-alpha (TNFa) for targeted therapy of medulloblastoma. In vitro and in vivo experiments showed that the TPA particle effectively and selectively delivered TNFa to medulloblastoma, leading to cell death and destruction of tumor blood vessels.
Review
Endocrinology & Metabolism
Jin Sung Son, Ryan Chow, Helena Kim, Toney Lieu, Maria Xiao, Sunny Kim, Kathy Matuszewska, Madison Pereira, David Le Nguyen, Jim Petrik
Summary: The study aims to identify and summarize the evidence on liposomal delivery of gene therapy for ovarian cancer. A total of 75 studies met the inclusion criteria out of 564 studies identified through electronic database search. Different types of liposomes were found, with cationic liposomes being the most studied. Eight areas of gene therapy research were identified, with microRNAs being the most frequently studied. Liposomal gene therapy has shown promising results in reducing tumor size and improving survival. Further research on the delivery and targets of gene therapy for ovarian cancer is recommended.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
(2023)
Article
Oncology
Jeremiah Wala, Paul Nguyen, Mark Pomerantz
Summary: The Oncology Grand Rounds series aims to provide clinical context for original reports published in the Journal of Clinical Oncology. This article discusses the use of androgen deprivation therapy (ADT) and the recent advancements in treatment for metastatic hormone-sensitive prostate cancer (mHSPC). The addition of second-generation oral androgen-receptor pathway inhibitors (ARPIs) or docetaxel to ADT has shown improved outcomes, and studies are also examining the role of radiotherapy (RT) in mHSPC.
JOURNAL OF CLINICAL ONCOLOGY
(2023)
Article
Medicine, General & Internal
Chih-Chien Wu, Chao-Wen Hsu, Meng-Che Hsieh, Jui-Ho Wang, Min-Chi Chang, Ching-Shiang Yang, Yi-Chia Su
Summary: The optimal sequence of treatment for patients with RAS wild-type metastatic colorectal cancer is not well established. Studies suggest that for second-line therapy, changing chemotherapy regimen with retention of bevacizumab may improve overall survival, while for patients treated with first-line CT plus anti-EGFR, second-line therapy of changed CT plus an anti-EGFR agent may result in better outcomes.
JOURNAL OF CLINICAL MEDICINE
(2021)
Review
Medicine, General & Internal
Leah H. Biller, Deborah Schrag
Summary: Colorectal cancer is the third most common cause of cancer mortality worldwide. For patients diagnosed with metastatic colorectal cancer, approximately 70% to 75% can survive beyond 1 year. Tailoring treatments based on the molecular and pathologic features of the tumor has shown to improve overall survival rates.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Article
Multidisciplinary Sciences
Sudpreeda Chainitikun, Sadia Saleem, Bora Lim, Vicente Valero, Naoto T. Ueno
Summary: The review focuses on the development of systemic treatment of IBC from the past to the present, including chemotherapy and targeted therapies. The effects on pathologic complete response (pCR), survival outcomes, predictive markers, and adverse events of these therapies are discussed, along with current standard treatment stratified by molecular subtypes. The future trend of systemic therapy, including immunotherapy and ongoing IBC clinical trials, is also addressed.
JOURNAL OF ADVANCED RESEARCH
(2021)
Review
Oncology
Thomas J. Ettrich, Thomas Seufferlein
Summary: Pancreatic cancer is often diagnosed at an advanced stage with poor prognosis, but chemotherapy has shown improvement in both survival and quality of life. Recent advancements include effective combination therapy options and targeted treatments for specific genetic mutations, highlighting the importance of early genetic testing for better treatment decisions.
CURRENT TREATMENT OPTIONS IN ONCOLOGY
(2021)
Article
Oncology
Kewen He, Hampartsoum B. Barsoumian, Duygu Sezen, Nahum Puebla-Osorio, Ethan Y. Hsu, Vivek Verma, Chike O. Abana, Dawei Chen, Roshal R. Patel, Meidi Gu, Maria Angelica Cortez, James W. Welsh
Summary: Multiple rounds of radiation therapy may provide greater clinical benefit by enhancing the adaptive immune response through repeated exposure to tumor antigens released by pulsed radiation therapy.
FRONTIERS IN ONCOLOGY
(2021)
Article
Nanoscience & Nanotechnology
Xiaoxi Wang, Xueqin Zhu, Bingyu Li, Xiuyu Wei, Yalan Chen, Yun Zhang, Yan Wang, Wenyan Zhang, Sijia Liu, Zimai Liu, Wenjie Zhai, Pingping Zhu, Yanfeng Gao, Zhenzhen Chen
Summary: An intelligent bionic nanoplatform combining targeted therapy with immunotherapy was developed to treat triple-negative breast cancer. In vitro and in vivo experiments demonstrated that this nanoplatform effectively inhibited the growth and metastasis of breast cancer and triggered an anti-tumor immune response.
ACS APPLIED MATERIALS & INTERFACES
(2022)
Review
Oncology
Marta Fudalej, Daria Kwasniewska, Pawel Nurzynski, Anna Badowska-Kozakiewicz, Dominika Mekal, Aleksandra Czerw, Katarzyna Sygit, Andrzej Deptala
Summary: Poor prognosis of pancreatic cancer (PC) is associated with several factors, such as diagnosis at an advanced stage, early distant metastases, and remarkable resistance to most conventional treatment options. The pathogenesis of PC seems to be significantly more complicated than originally assumed. To develop effective treatment schemes prolonging patient survival, a multidirectional approach encompassing different aspects of the cancer is needed. Further studies bringing together different therapeutic strategies are required. This review provides an overview of new or emerging therapeutic strategies for the more effective management of metastatic PC.
Article
Chemistry, Multidisciplinary
Pingjin Zou, Rui Lin, Zengyi Fang, Junyang Chen, Hongye Guan, Jie Yin, Zhiheng Chang, Lili Xing, Jinyi Lang, Xinyu Xue, Meihua Chen
Summary: The self-powered photodynamic therapeutic tablet, which integrates a ferroptosis inducer, enhances ferroptosis and achieves a tumor inhibition rate of over 85%. By generating reactive oxygen species and accelerating lipid peroxidation, the tablet addresses the limitations of traditional treatments and reduces medication dosage.
Article
Medicine, General & Internal
J. N. Jarvis, D. S. Lawrence, D. B. Meya, E. Kagimu, J. Kasibante, E. Mpoza, M. K. Rutakingirwa, K. Ssebambulidde, L. Tugume, J. Rhein, D. R. Boulware, H. C. Mwandumba, M. Moyo, H. Mzinganjira, C. Kanyama, M. C. Hosseinipour, C. Chawinga, G. Meintjes, C. Schutz, K. Comins, A. Singh, C. Muzoora, S. Jjunju, E. Nuwagira, M. Mosepele, T. Leeme, K. Siamisang, C. E. Ndhlovu, A. Hlupeni, C. Mutata, E. van Widenfelt, T. Chen, D. Wang, W. Hope, T. Boyer-Chammard, A. Loyse, S. F. Molloy, N. Youssouf, O. Lortholary, D. G. Lalloo, S. Jaffar, T. S. Harrison
Summary: The study shows that a treatment regimen that includes a single high dose of liposomal amphotericin B combined with flucytosine and fluconazole is noninferior to the current WHO-recommended treatment for HIV-related cryptococcal meningitis in sub-Saharan Africa, with fewer adverse events.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Chemistry, Multidisciplinary
Gui Chen, Qing Xu, Zhenzhen Feng, Qinqin Xu, Xuhui Zhang, Yuanyuan Yang, Yuxuan Zhang, Xing-Jie Liang, Zhiqiang Yu, Meng Yu
Summary: Electrodynamic therapy combined with nanotechnology was used to generate highly cytotoxic oxidative radicals for tumor destruction. However, single EDT treatment faces challenges in long-term tumor suppression in an immunosuppressive environment. In this study, a combination therapy of EDT and immunotherapy was designed using a nanocarrier loaded with a glutamine antagonist, which stimulated a protective immune response and demonstrated great therapeutic efficacy in primary and metastatic tumor models.
Article
Chemistry, Multidisciplinary
Tarik Bozoglu, Seungmin Lee, Tilman Ziegler, Victoria Jurisch, Sanne Maas, Andrea Baehr, Rabea Hinkel, Amelie Hoenig, Anjana Hariharan, Christina Inyeop Kim, Simon Decker, Haider Sami, Tobias Koppara, Ruppert Oellinger, Oliver J. Muller, Derk Frank, Remco Megens, Peter Nelson, Christian Weber, Angelika Schnieke, Markus Sperandio, Gianluca Santamaria, Roland Rad, Alessandra Moretti, Karl-Ludwig Laugwitz, Oliver Soehnlein, Manfred Ogris, Christian Kupatt
Summary: The study demonstrates a method of retargeting adeno-associated viruses (AAVs) to endothelial cells by coating them with second-generation polyamidoamine dendrimers (G2) linked to endothelial-affine peptides (CNN). This approach improves gene transfer efficiency, potentially enabling applications in vascular and atherosclerosis models.
Article
Pharmacology & Pharmacy
Simon Decker, Alexander Taschauer, Emanuela Geppl, Viktoria Pirhofer, Michael Schauer, Stephan Poschl, Florian Kopp, Lars Richter, Gerhard F. Ecker, Haider Sami, Manfred Ogris
Summary: In this study, GE11 variants with improved binding were designed using a computational approach and their efficacy in transfection studies was validated.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
(2022)
Article
Chemistry, Multidisciplinary
Julia Giselbrecht, Shashank Reddy Pinnapireddy, Fatih Alioglu, Haider Sami, Daniel Sedding, Frank Erdmann, Christopher Janich, Michaela Schulz-Siegmund, Manfred Ogris, Udo Bakowsky, Andreas Langner, Jeroen Bussmann, Christian Woelk
Summary: This study investigates in vivo nucleic acid delivery using simpler models to overcome the limitations of in vitro experiments in predicting in vivo efficacy. The results demonstrate that the OH4:DOPE formulation is effective in transfecting complex tissues and zebra fish embryos.
Review
Chemistry, Multidisciplinary
Ricarda Carolin Steffens, Ernst Wagner
Summary: Nucleic acid therapeutics have emerged as a promising treatment for a variety of diseases, including genetic disorders and cancer. They have also been effectively utilized as vaccines during the COVID-19 pandemic. However, in order to maximize their therapeutic potential, these nano agents must overcome various obstacles, particularly the challenge of targeted transport to specific tissues and cell types.
PHARMACEUTICAL RESEARCH
(2023)
Article
Oncology
Carolin Kitzberger, Rebekka Spellerberg, Yang Han, Kathrin A. Schmohl, Christina Stauss, Christian Zach, Roland E. Kaelin, Gabriele Multhoff, Matthias Eiber, Franz Schilling, Rainer Glass, Wolfgang A. Weber, Ernst Wagner, Peter J. Nelson, Christine Spitzweg
Summary: In this study, genetically engineered MSCs carrying the NIS gene were injected into mice to treat experimental glioblastoma. The results showed that NIS-MSCs successfully homed to the tumor and expressed the NIS gene, and subsequent treatment with therapeutically effective radioiodide (131I) significantly delayed tumor growth and prolonged mouse survival.
CLINICAL CANCER RESEARCH
(2023)
Article
Chemistry, Multidisciplinary
Yi Lin, Ulrich Wilk, Jana Poehmerer, Elisa Hoerterer, Miriam Hoehn, Xianjin Luo, Hongcheng Mai, Ernst Wagner, Ulrich Laechelt
Summary: The CRISPR/Cas9 system provides opportunities for precise modification of the genome to treat various diseases. This study presents Cas9 RNP nanocarriers based on lipid-modified oligoamino amides and folic acid (FolA)-PEG for receptor-mediated uptake and gene editing in cancer cells. The nanocarriers achieve efficient knockout of GFP, PD-L1, and PVR genes, and exhibit superior gene editing and tumor growth inhibition compared to non-targeted nanoparticles in an in vivo mouse model.
Article
Chemistry, Multidisciplinary
Sophie Thalmayr, Melina Grau, Lun Peng, Jana Poehmerer, Ulrich Wilk, Paul Folda, Mina Yazdi, Eric Weidinger, Tobias Burghardt, Miriam Hoehn, Ernst Wagner, Simone Berger
Summary: By combining cationizable lipids and polymers, we have developed highly potent pH-responsive nucleic acid carriers for efficient intracellular delivery. These carriers exhibit tunable polarity and structural changes in response to pH, allowing for dynamic nucleic acid delivery. Through optimization of topologies, LAF types, and LAF/aminoethylene ratios, we have identified carriers that are up to several 100-fold more efficient than previous generations and maintain activity in the presence of serum. Importantly, these carriers show excellent in vivo performance, particularly in the spleen, tumor, lungs, and liver.
ADVANCED MATERIALS
(2023)
Article
Chemistry, Multidisciplinary
Paul Strasser, Bianca Montsch, Silvia Weiss, Haider Sami, Christoph Kugler, Sonja Hager, Hemma Schueffl, Robert Mader, Oliver Brueggemann, Christian R. R. Kowol, Manfred Ogris, Petra Heffeter, Ian Teasdale
Summary: The design and synthesis of novel bottlebrush polymers (PPz-g-PGA) with exceptional control over their structure and molecular dimensions have been reported. These polymers show outstanding aqueous solubility, ultra-high multivalency, and biodegradability, making them ideal as nanomedicines. They exhibit enhanced cellular uptake, pharmacokinetics, and tumor accumulation, offering valuable insights into the influence of architecture on the in vivo performance of nanomedicines.
Article
Pharmacology & Pharmacy
Faqian Shen, Yi Lin, Miriam Hoehn, Xianjin Luo, Markus Doeblinger, Ernst Wagner, Ulrich Laechelt
Summary: This study presents a versatile platform for the cellular delivery of various cargo peptides by integrating them into metallo-peptidic coordination nanoparticles. These nanoparticles can enhance the stability and membrane permeability of the peptides, making them efficient in delivering bioactive cargos into cells. The nanoparticles also generate reactive oxygen species (ROS) in cells, further enhancing their therapeutic potential.
Article
Chemistry, Multidisciplinary
Alessio Malfanti, Haider Sami, Anna Balasso, Giulia Marostica, Busra Arpac, Francesca Mastrotto, Giuseppe Mantovani, Elisa Cola, Martina Anton, Paolo Caliceti, Manfred Ogris, Stefano Salmaso
Summary: Studies have shown that liposomes decorated with OCE and PEG have advantages in nucleic acid delivery, improving stability and reducing toxicity. OCE decoration increases liposome adhesion and uptake, while PEG coating reduces hemolysis and cytotoxicity. Treatment with chloroquine can optimize the time window for endo-lysosomal escape.
JOURNAL OF CONTROLLED RELEASE
(2023)
Article
Chemistry, Multidisciplinary
Yi Lin, Xianjin Luo, Tobias Burghardt, Sarah Dorrer, Miriam Hoehn, Ernst Wagner, Ulrich Laechelt
Summary: This study reports a series of artificial peptides based on novel ionizable amino acids that efficiently deliver Cas9 RNP into cells. The relationship between the xenopeptide logD(7.4) and genome editing potency was revealed through systematic variation of hydrophobic properties. The optimized amphiphilic carriers enable high levels of eGFP knockout and homology-directed repair (HDR) in reporter cells, and mechanistic studies show that hydrophobically balanced xenopeptides are more resistant to stress and promote endocytosis.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
(2023)
Article
Polymer Science
Fengrong Zhang, Teoman Benli-Hoppe, Wei Guo, Johanna Seidl, Yi Wang, Rongqin Huang, Ernst Wagner
Summary: Carbon nanodots have great potential in bioimaging applications due to their resistance to photobleaching, bright photoluminescence, and superior biocompatibility. In this study, researchers used four-armed oligomers caged with a novel ligand reL57 to enhance cellular uptake of nanoprobes. The study also highlighted the importance of incorporating epsilon-amino-linked lysines in the development of the oligomers, which significantly extended their contour length per monomer.
Article
Biochemistry & Molecular Biology
Yanira Zeyn, Dominika Hobernik, Ulrich Wilk, Jana Poehmerer, Christoph Hieber, Carolina Medina-Montano, Nadine Roehrig, Caroline F. Straehle, Andrea K. Thoma-Kress, Ernst Wagner, Matthias Bros, Simone Berger
Summary: A deeper understanding of the role of the tumor microenvironment in cancer development has led to the development of new strategies, such as gene-based cancer immunotherapy. This study tested the concept of DC-focused transcriptional targeting by modifying and optimizing plasmids to achieve specific gene expression in antigen-presenting cells.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Oncology
Bianca Koehler, Sviatlana Dubovik, Elisa Hoerterer, Ulrich Wilk, Jan Bernd Stoeckl, Hande Tekarslan-Sahin, Bojan Ljepoja, Philipp Paulitschke, Thomas Froehlich, Ernst Wagner, Andreas Roidl
Summary: Resistance formation of cancer cells to chemotherapy is a major obstacle in cancer therapy. This study investigates the role of hsa-miR-200c in regulating drug resistance and finds that it sensitizes cancer cells to chemotherapy and reverses drug resistance. The results suggest that hsa-miR-200c could serve as a prognostic marker and a potential therapeutic option for cancer therapy.
Review
Biophysics
Simone Berger, Martin Berger, Christoph Bantz, Michael Maskos, Ernst Wagner
Summary: Nanomedicine has the potential to transform therapy, but current in vitro experiments have limited predictive power for in vivo performance. More realistic in vitro experiments are needed to reduce animal testing and identify promising candidates. Understanding the formation process of the protein corona, which plays a crucial role in nanoparticle characteristics, is important. Different methods for studying the protein corona and its impact on nanoparticles are reviewed. This information can be used to optimize nanoparticles for in vivo applications, although the transition from in vitro to in vivo remains challenging. Functional in vitro screening in physiological conditions and innovative in vivo screening using barcoded nanoparticles are recommended.
BIOPHYSICS REVIEWS
(2022)